Compare WALD & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WALD | HRZN |
|---|---|---|
| Founded | 1988 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Finance/Investors Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.7M | 275.7M |
| IPO Year | 2021 | 2010 |
| Metric | WALD | HRZN |
|---|---|---|
| Price | $1.55 | $6.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $4.88 | ★ $7.13 |
| AVG Volume (30 Days) | 93.9K | ★ 739.7K |
| Earning Date | 11-24-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 19.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $274,560,000.00 | $98,899,000.00 |
| Revenue This Year | $4.61 | $3.03 |
| Revenue Next Year | $11.22 | $10.24 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.22 | N/A |
| 52 Week Low | $1.45 | $5.71 |
| 52 Week High | $4.10 | $9.99 |
| Indicator | WALD | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 30.29 | 59.07 |
| Support Level | $1.45 | $6.49 |
| Resistance Level | $1.64 | $6.38 |
| Average True Range (ATR) | 0.13 | 0.13 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 12.07 | 96.81 |
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.